This is from their Latest CSE F7.
"services offered by Sona:
a) Conjugation service: Sona can combine its unique gold nanorods with biologicals provided by customers to offer a fully optimized and customized conjugate for their lateral flow assays, reducing customer’s development time.
b) Lateral flow test development: Sona is providing a tailored, modular contract development service from proof of concept through to full development and transfer to production, helping customers bring tests to market.
c) Lateral flow test production: Sona is partnering with world-class, third party manufacturers to manufacture pilot and validation batches through to large-scale bulk volumes to serve customer’s market needs.
d) R&D consultancy service: Sona has over 60 years of combined R&D experience in lateral flow assay production which is now offered as consultancy service for customer’s product development and commercialization."
This clarifies that SONA is a dx test marriage maker. They get the product ready for commercial production and customer's FDA, 510k, CE Nark etc approval. SONA would get an upfront or ticket clip or by the look of it a combination. Anteo will be dealing directly with each of SONA's clients for royalties.
Also in the report it shows, SONA's prefered POC device is the German company opTricon and Bond Digital Health software & records base "co-marketing agreement with opTricon GmbH a market leader on point of care diagnostics devices. With opTricon’s cutting edge cube reader system and our break through gold nanorod technology, Sona is envisioning to be a leader in the lateral flow assay market.The “cube” is the next generation of test readers- small, compact, user-friendly, intuitive, wireless, cost effective and provides clear results in minutes. It serves as a virtual “electronic eye” to turn qualitative tests into quantitative tests.Sona has entered a co-marketing agreement with Bond Digital Health solutions a leading SAAS platform development company from UK. Bond has developed an app to be connected with the opTricon cube reader system to gather, store and analyze lateral flow test data effectively. Bond’s data capture software is ideal for lateral flow assays as it turns basic qualitative tests into informative quantitative tests. This, coupled with Bond’s patient record system, provides the perfect companion app to healthcare professionals and home test consumers conducting self-monitoring."
Sweet spot for Anteo! - this deal offers one offs tests all the way through to clinical packages.
- Forums
- ASX - By Stock
- ADO
- Ann: Anteo Technologies Signs Collaboration with Sona Nanotech
Ann: Anteo Technologies Signs Collaboration with Sona Nanotech, page-67
-
-
- There are more pages in this discussion • 329 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
-0.002(6.52%) |
Mkt cap ! $53.07M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.2¢ | $20.42K | 928.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1118907 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 7380 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1118907 | 0.021 |
13 | 4461723 | 0.020 |
6 | 1464605 | 0.019 |
9 | 2336112 | 0.018 |
4 | 432891 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 7380 | 2 |
0.023 | 899841 | 4 |
0.024 | 225300 | 2 |
0.025 | 1138770 | 9 |
0.027 | 250000 | 1 |
Last trade - 15.45pm 05/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |